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Abstract
Background: The combination of poverty, HIV and depression in the perinatal period represents a major public
health challenge in many Southern African countries. In some areas, up to a third of HIV-positive women
experience perinatal depression. Perinatal depression is associated with negative effects on parenting and key
domains of child development including cognitive, behavioural and growth, especially in socio-economically
disadvantaged communities. Several studies have documented the benefits of psychological interventions for
perinatal depression in low- and middle-income countries, but none have evaluated an integrated psychological
and parenting intervention for HIV-positive women using task-sharing. This randomised controlled trial aims to
evaluate the effect of a home-based intervention, combining a psychological treatment for depression and a
parenting programme for perinatally depressed HIV-positive women.
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: alan.stein@psych.ox.ac.uk
2DSI-NRF Centre of Excellence in Human Development, University of the
Witwatersrand, Johannesburg, South Africa
4DSI-MRC South African Population Research Infrastructure Network (SAPRIN),
Durban, South Africa
Full list of author information is available at the end of the article
Rochat et al. Trials          (2021) 22:914 
https://doi.org/10.1186/s13063-021-05672-0
Methods: This study is a cluster randomised controlled trial, consisting of 48–60 geospatial clusters. A total of 528
pregnant HIV-positive women aged ≥ 16 years who meet the criteria for depression on the Edinburgh Postnatal
Depression Scale (EPDS, score ≥ 9)) are recruited from antenatal clinics in rural KwaZulu-Natal, South Africa. The
geospatial clusters are randomised on an allocation ratio of 1:1 to either the intervention or Enhanced Standard of
Care (ESoC). The intervention group receives 10 home-based counselling sessions by a lay counsellor (4 antenatal
and 6 postnatal sessions) and a booster session at 16 months. The intervention combines behavioural activation for
depression with a parenting programme, adapted from the UNICEF/WHO Care for Child Development programme.
The ESoC group receives two antenatal and two postnatal counselling support and advice telephone calls.
In addition, measures have been taken to enhance the routine standard of care.
The co-primary outcomes are child cognitive development at 24 months assessed on the cognitive subscale of the
Bayley Scales of Infant Development-Third Edition and maternal depression at 12 months measured by the EPDS.
Analysis: The primary analysis will be a modified intention-to-treat analysis. The primary outcomes will be analysed
using mixed-effects linear regression.
Discussion: If this treatment is successful, policymakers could use this model of mental healthcare delivered by lay
counsellors within HIV treatment programmes to provide more comprehensive services for families affected by HIV.
Trial registration: ISRCTN registry #11284870 (14/11/2017) and SANCTR DOH-27-102020-9097 (17/11/2017).
Keywords: Perinatal depression, Behavioural activation, HIV, Parenting, Child development, Lay counsellors
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Introduction
Background and rationale {6a}
Perinatal depression in the context of HIV
Perinatal depression is common amongst HIV-
positive women globally and a major public health
challenge [1, 2]. A 2015 systematic review of African
studies of perinatal depression amongst HIV-positive
women reported rates between 23.4 and 43.5% in the
antenatal and 22.5 and 31% in the postnatal periods
[3]. More recently, a global meta-analysis comparing
rates of depression amongst HIV-positive and HIV-
negative women in both the antenatal and postnatal
periods, found that HIV-positive women had signifi-
cantly higher odds of depressive symptoms [2]; 36%
of HIV-positive women experienced antenatal de-
pression compared to 26% of HIV-negative women,
whilst 21% of HIV-positive women experienced post-
natal depression compared to 16% of HIV-negative
women. Given that up to a third of all women at-
tending antenatal services in Southern Africa are
HIV-positive, these differences are clinically
important.
Perinatal depression may contribute both directly
and indirectly to a wide range of maternal and child
health risks [4, 5]. Studies show that perinatal
depression amongst HIV-positive women is associ-
ated with increased suicidal ideation, with rates as
high as 40% in some studies [3, 6]. Amongst HIV-
positive women, perinatal depression has been asso-
ciated with lower clinic attendance and poor adher-
ence to antiretroviral treatment (ART) [7, 8]. A
recent systematic review and meta-analysis estimated
that, for people living in sub-Saharan Africa, depres-
sion approximately doubled the odds of non-
adherence (OR 2.54 95% CI [1.7-3.9]) [9]. Psycho-
logical therapies, especially those using cognitive be-
havioural approaches have been shown to improve
both depression and adherence to ART in the USA
[10, 11], although more evidence is needed in Afri-
can countries [12].
The potential impact of perinatal depression on
parenting and child development is of major
concern. Studies have consistently shown that
perinatal depression is associated with negative
effects on children’s cognitive, language, behavioural
and emotional development as well as growth,
including risks of stunting [5, 13]. The persistence of
depression appears to be more likely to lead to
negative effects on the child [14], highlighting the
need for treatment. The quality of caregiving is a
key mediator of the negative effects of parental
depression on child development. An important
reason for this is the effects of rumination, a core
characteristic of cognition in depression, on
responsiveness to a young child [15]. Rumination
consists of recurrent negative thoughts that are
intrusive and difficult to dismiss, absorb attention
and are associated with reduced problem-solving,
speed of response to external stimuli and distur-
bances in attention. This is important because fo-
cused maternal attention to the infant and
contingent responsiveness to infant cues and behav-
iour is essential to early cognitive and emotional
childhood development. Furthermore, depression dis-
rupts the ability to scaffold and support an infant’s
exploratory behaviour and emotional states, espe-
cially infant distress and this can disrupt emotional
and behavioural development [5, 16].
Finally, maternal depression may affect child
growth, gastrointestinal and respiratory infections,
and general health through a shorter duration of
exclusive breastfeeding (EBF) and lower rates of
health and hygiene promoting behaviours [17, 18].
EBF is of particular importance in HIV-positive pop-
ulations as studies have found that optimal early-life
feeding practices ameliorate the effects of being born
to an HIV-positive mother [19]. Furthermore, EBF
has been shown to reduce episodes of diarrhoea in
infants born to HIV-positive mothers [20].
Consequently, maternal depression in the context of
HIV is associated with several maternal and child health
risks. The combination of HIV and depression in the
perinatal period is especially important because the
negative impact of depression on children is amplified
by socio-economic adversity and lack of support [4, 5],
which are associated with HIV [21]. Thus, the clinical
implications of perinatal depression amongst HIV-
positive women are likely extensive in HIV-endemic
regions.
These effects of depression in the context of HIV
on child development forms part of a growing body
of literature underscoring the importance of early-
life exposures for long-term health and development
[22–24]. As a result, international agencies, including
the World Health Organization, are developing
evidence-based policies and interventions aiming to
improve early child development, encapsulated in the
Nurturing Care Framework [25]. The Nurturing Care
Framework has two guiding implementation features;
firstly, to ensure the child receives multiple interven-
tion inputs required to support healthy development,
including adequate nutrition and health, early learn-
ing opportunities, safety and security and responsive
care. Secondly, the framework attends to the enab-
ling environment of care, including the mental
health of caregivers and their support [24]. The
present study is situated within this new scientific
and policy focus.
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Interventions for perinatal depression in LMIC
In recent years, task-shifting of mental health care
services to trained lay health care workers has been
strongly advocated for in an effort to increase treat-
ment coverage for mental health disorders in LMICs
[26, 27]. A range of intervention studies in LMICs
have used task-shifting to community health workers
(CHW) or lay counsellors to support women with
perinatal depression. Internationally, such studies re-
port that psychological treatment by peer or lay coun-
sellors is feasible and generally has positive effects
compared to routine standard of care [27]. A 2014 re-
view of nine South African psycho-social interventions
delivered by CHWs or lay counsellors (several of
which targeted pregnant women) reported that the
majority of studies provided evidence for the effect-
iveness of task-shifted interventions which include
psychological content [28], although one recent RCT
in South Africa for perinatal depression, not specific-
ally targeting HIV-positive women, did not report sig-
nificant effects on maternal mood [29].
There has been one example of a randomised
controlled treatment trial (Masihambisane Trial)
which tested the effectiveness of a clinic-based peer-
mentor support intervention addressing health, in-
cluding mental health, and stigma faced by perinatal
HIV-positive women (not necessarily experiencing
depression) in rural KwaZulu-Natal, South Africa.
This study showed improvements in maternal mental
health but also found that centre-based activities
presented significant challenges to retention [30]. To
our knowledge, only one published RCT in Africa
has directly tested the effects of an intervention spe-
cifically for HIV-positive pregnant women on peri-
natal depressive symptoms (and prenatal disclosure
rates of HIV). The trial compared a 6-week psycho-
social support group facilitated by nursing staff with
the standard of care (SoC) in Dar es Salam,
Tanzania. The trial found that marginal non-
significant improvements in the intervention arm
compared to the SoC arm and there was a high at-
trition rate [31].
In addition to Kaaya et al. (2013) [31], other studies
in LMICs have reported high attrition rates in clinic-
and group-based studies exploring mental health in-
terventions in HIV-positive populations. Petersen
et al. reported an attrition rate higher than 45% in a
randomised controlled pilot study of group-based
interpersonal therapy intervention for depressed HIV-
positive patients in South Africa [32]. The low uptake
of the intervention was attributed to limited transport
opportunities and money, employment responsibilities
on treatment days and discomfort with the group ap-
proach (particularly gender and age similarities were
cited as important for ensuring comfort in relaying
sensitive issues). As mentioned above, the Masihambi-
sane found low uptake of sessions in a clinic-based
peer-mentor intervention for HIV-positive women in
the perinatal period, citing opportunities and costs
and clinic waiting times as significant barriers to
clinic-based interventions [30]. In contrast, home-
based interventions for HIV-positive women in South
Africa have been documented to reach more than
98% of women and follow-up rates were more than
91% at 6 months [33]. Thus, in the present study, we
planned to use a home-based individual intervention
to overcome some of the barriers to clinic-based
group interventions.
Interventions for parenting in LMIC
Parenting interventions that support caregivers and
provide guidance on practices and skills that help
caregivers to support their young child’s development
have been beneficial in improving early childhood
development (ECD) outcomes and reducing risks of
developmental delay. The most recent global meta-
analysis of parenting interventions, comprising 90
RCTs, found small (β = 0.19, socioemotional) to
medium (β = 0.31–0.34, cognitive and language) ef-
fects on ECD. It is noteworthy that interventions that
included strategies to support responsive caregiving
had stronger effects on children’s development [34],
however, there are evidence gaps. Firstly, only a small
number of parenting interventions implemented in
LMIC evaluated children’s early socioemotional devel-
opment. Secondly, fewer interventions have assessed
caregiver mental health. In a review that examined
care outcomes for parenting interventions in LMIC,
nine of the 15 interventions assessed maternal depres-
sive symptoms and the meta-analyses did not report
any significant reduction in depressive symptoms [35].
Parenting interventions that include components to
promote mental health, rather than focusing only on
the needs of the child, are likely to be beneficial for
children and their caregivers [36]. More research is
needed on how these interventions can be effectively
combined and tailored to the needs of at-risk
families.
To our knowledge, the present study is the first to test
a home-based integrated intervention specifically target-
ing HIV-positive, perinatally depressed women, which
combines treatment for depression with a parenting
intervention delivered by lay counsellors.
The Insika Yomama intervention
In this trial, we test a novel integrated intervention to
treat HIV-positive perinatally depressed women and
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enhance child development, using a combination and
adaptation of two evidence-based interventions: (i) be-
havioural activation (BA) for depression and (ii) and
the WHO/UNICEF Care for Child Development
(CCD) package.
Behavioural activation (BA) is being trialled because
it has been shown to be as effective as cognitive
behavioural therapy (CBT) in high-income settings
[37–39]. BA is easier to deliver than CBT since it
does not require extensive training or complex coun-
selling skills. Studies suggest that BA delivered by
non-specialists appear similar to those with formal
therapy qualifications [40]. Importantly, studies report
that BA is effective in treating depression in LMIC
when delivered by a range of non-specialist health
care workers [41]. As a result, BA lends itself to task-
shifting [42, 43]. In South Africa, the National Mental
Health Policy Framework (2013–2020) acknowledges
task-shifting as a critical approach to improving men-
tal health nationally [44, 45]. Furthermore, BA is con-
sidered to be suitable for cross-cultural delivery
because it targets behavioural change rather than be-
liefs and attitudes. To date, BA has not been tested
amongst HIV-positive women in the perinatal period.
The WHO/UNICEF CCD package was developed to
promote early childhood development, especially
cognitive development, through responsive caregiving
and early stimulation [46, 47]. Evaluations of CCD
implementation have shown that the CCD strategy
can be feasibly delivered by CHWs and there is good
acceptability and demand from families [23, 48, 49].
Meta-analyses have shown significant benefits from
programmes that support parents to enhance early
stimulation as a means to improve early child cogni-
tive development, including language development
[50]. The CCD package has also been adapted and
evaluated in several LMIC with positive results al-
though it has not yet been tested in the context of
perinatal depression or HIV, nor does it include con-
tent for pregnant women [50, 51]. Thus, the present
trial is the first to adapt the CCD package for peri-
natally depressed, HIV-positive women. Furthermore,
in this study, CCD has been augmented with specific
content to begin during pregnancy including visual
aids for lay counsellors, including information sheets
and handouts.
Objectives {7}
The primary objective is to test whether a home-based
intervention, integrating behavioural activation for de-
pression with a parenting programme adapted from
CCD, for HIV-positive women with perinatal depression
compared to Enhanced Standard of Care (ESoC)
improves:
1. Maternal perinatal depression at 12 months
postnatal
2. Child cognitive development at 24 months of age
Secondary objectives:
To identify if the combined intervention compared to
the ESoC:
1. Improves maternal depression at end of pregnancy1
and 24 months postnatal.
2. Improves maternal anxiety at the end of pregnancy
and 24 months postnatal.
3. Increases maternal adherence to Antiretroviral
Treatment (measured as viral load (VL) and viral
suppression post-initiation of treatment) over the
trial period.
4. Increases rates of exclusive breastfeeding to six
months postnatal.
5. Improves adherence to infant immunisation
schedule over the 24-month postnatal period.
6. Reduces episodes of diarrhoea over the postnatal
period2.
7. Improve the quality of infants’ cognitive and
emotional stimulation within the home
environment at 12 and 24 months.
8. Reduces child behavioural difficulties at 12 and 24
months postnatal.
9. Improves child language development at 24 months
postnatal.
10. Improves child growth (infant height and weight) at
24 months postnatal.
Trial design {8}
A cluster randomised controlled superiority trial with two
parallel groups. The trial comprises 48–60 neighbourhood
clusters, randomly allocated to the combined intervention
or ESoC using a 1:1 allocation ratio with approximately
9–11 participants (mothers) per cluster, totalling 528
mother-infant pairs.
Methods: participants, interventions and
outcomes
Study setting {9}
The trial is being conducted at the Africa Health
Research Institute (AHRI) Somkhele Research Campus
in rural Northern KwaZulu-Natal, South Africa, within
AHRI’s Population Intervention Platform demographic
surveillance area. The study area covers 845 km2 and the
community is predominantly rural but contains an
urban township and informal peri-urban settlements [53,
1‘End of pregnancy’ refers to ~ 35 weeks of gestation in this paper.
2Episodes of diarrhoea are defined as maternal report of diarrhoea in
the previous 14 days [52]
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54]. The resident population is approximately 100,000
people (~ 20,000 households) of which the majority are
isiZulu-speaking. The area includes one district-level
hospital and 17 primary healthcare facilities. A 2019
study of a prospectively followed, population-based co-
hort from the study area estimated that HIV prevalence
amongst women aged 15–54 years of age in the study
area increased from 25 to 41% between 2005 and 2017
[55]. Despite high HIV prevalence, the incidence of HIV
infection declined between 2012 and 2017 with men ex-
periencing the biggest declines. Prevention of Mother-
to-Child Transmission services were implemented in the
sub-district in 2001 along with an HIV treatment
programme in 2004 providing ART through public
health facilities [56]. ART treatment is delivered in a
decentralised model at primary health care clinics. Con-
sistent with WHO guidance, all pregnant women not
already on ART are initiated on ART treatment for life,
irrespective of CD4+ count.
Eligibility criteria {10}
Participants provide written, informed consent both
before screening and again if they fulfil all eligibility
criteria before any trial activities, including randomisation,
proceed. Minors (≥16 and < 18 years of age) provide
guardian/parental consent as well as their assent to
participate. The participant flow is outlined in Fig. 1.
Inclusion criteria:
 Pregnant women, 23–33 weeks of gestation at the
time of enrolment;
 Participant willing and able to give informed consent
for participation in the trial;
 Aged 16 years and above;
 Diagnosed HIV-positive;
 Participant meets the criteria for antenatal
depression as defined by a score of ≥ 9 on the EPDS;
 Living, or planning to live, within the study area at
the time of delivery and for at least 9 months after
delivery (the intensive therapy period);
 Participant is conversant in isiZulu or English.
Exclusion criteria:
The participant may not enter the trial if any of the
following apply:
 Any significant disease, disorder, or disability which,
in the opinion of the Principal Investigator, may
either put the participants at risk because of
participation in the trial, or may influence the result
of the trial, or the participant’s ability to participate
in the trial. This includes hospitalisation for at least
3 days for severe psychiatric illness (specifically
bipolar disorder, schizophrenia and any other
psychoses), or a life-threatening or other serious
physical illness (excluding HIV and tuberculosis).
 Current suicidal ideation/thoughts with specific
plans and means identified.
 Substance or alcohol use disorder.
 Currently receiving psychological treatment for
mental health problems.
 Participant planning to move away from the study
area before 9 months postnatal.
 Participant not planning to cohabit with the infant.
Who will take informed consent? {26a}
Screening consent is obtained before screening
procedures. If potential participants are not able to be
screened at the first meeting, initial consent to contact is
obtained. The full informed consent is explained at the
enrolment visit at the clinic and confirmed at the
baseline assessment. For participants < 18 years, full
guardian consent is obtained in addition to adolescent
assent. Informed consent, confidentiality and data
handling comply with Good Clinical Practice (GCP)
regulations. The consent processes are conducted by
trained recruiters who are supervised and monitored by
a recruitment supervisor and the trial coordinator.
Additional consent provisions for collection and use of
participant data and biological specimens {26b}
No biological specimens will be collected in the trial.
Interventions
Explanation for the choice of comparators {6b}
Eligible participants are randomised in clusters to either
the intervention or the Enhanced Standard of Care (ESoC)
arms. The explanation for the choice of the intervention
arm, which comprises a combination of behavioural
activation (BA) and a parenting programme based on the
WHO/UNICEF ‘Care for Child Development’ (CCD), is
described in detail in the introduction (see ‘The Insika
Yomama intervention’).
Enhanced Standard of Care (ESoC) was chosen as the
control arm to provide telephonic counselling support and
advice which also ensures that participants are helped to
access care and referrals are made where necessary. The
counselling support intervention includes four support and
advice phone calls. The ESoC call programme was
informed by the enhanced care package used in a recent
perinatal depression trial in South Africa [57]. The standard
of care in the study community is described in detail below.
Intervention description {11a}
Therapy intervention
The intervention, integrating a psychological treatment
for maternal depression and a parenting intervention to
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enhance early childhood development, is based on two
evidence-based interventions delivered at the home:
(1) Behavioural activation (BA) is a structured
therapeutic approach that emphasises
environmental causes of depression [37]. It is based
on the evidence that increased activity (i.e.
activation), and the resulting positive consequences,
leads to a reduction of depressive symptoms. BA
helps people understand the interaction between
Fig. 1 Participant flow
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individual and environmental sources of their
depression, and targets behaviours that might
maintain or worsen the depression. Thus, BA aims
to increase behaviours that are personally rewarding
to improve mood and quality of life and decreases
behaviours that maintain or worsen depression,
such as passivity, avoidance and rumination. BA
introduces small behavioural changes, building up
the level of activity gradually towards long-term
goals, making it feasible for perinatal women with
limited time to spare.
(2) WHO/UNICEF Care for Child Development (CCD)
package is a parenting intervention that aims to
enhance early childhood development, especially
cognitive development, through improving
parenting skills. The Insika Yomama parenting
intervention tested in this study is adapted from the
evidence-based CCD programme and aims to pro-
mote responsive caregiving and early stimulation. In
this trial, we include specific pregnancy modules
and visual aids to assist the delivery of the parenting
content. The parenting component is designed to
be integrated complementary to the BA component
by ensuring that parenting activities enhance access
to positive reinforcement through rewarding care-
giving experiences, especially around responsive-
ness, thus potentially improving both mood and
quality of parenting concurrently.
The participant is allocated a lay counsellor who
provides all 10 sessions and the booster session.
Session structure The combined intervention is
delivered by lay counsellors in the participants’ homes
across 10 sessions, starting in pregnancy (between 26 and
36 weeks of gestation) through to 9 months postnatal,
along with an additional booster session at 16months
postnatal. The initial session lasts up to 2 h and focuses on
orientation to BA and assessment of behaviours around
depression using a BA diagram to conceptualise problem
behaviours. The session focuses on BA only. The
remaining sessions last approximately 1.5 h each,
compromising combined mother-focused BA modules
and infant-focused parenting components. The therapy
arm also receives a ‘keep in contact call’ at 36–38 weeks of
gestation between therapy session 4 and delivery.
Materials Electronic tablets assist the lay counsellors in
delivering the combined intervention and keeping track
of participants’ developments and session content. The
tablets contain visual aids and a treatment manual. The
treatment manual has been developed to guide the lay
counsellors in providing standardised BA activities. This
is accompanied by handouts containing exercises and
health information relating to antenatal care,
breastfeeding, management of infant crying and HIV
treatment are provided for participants to accompany
the sessions.
The BA comprises:
 Assessment—Session 1 is an orientation to BA
(explanation of core concepts); psychoeducation
around self-care, routines, and nourishing activities
(i.e. activities one enjoys doing); and setting of treat-
ment goals.
 Activating activities—Sessions 2–6 cover the core
BA content. The treatment manual includes
modules on self-care (sleep, eating, exercise), adher-
ence to medication, routines, nourishing activities
(e.g. bath with privacy) and problem-solving. Each
module focuses on behavioural change that increases
positive reinforcement and reduces avoidance behav-
iour. By the end of each session, homework is dis-
cussed (e.g. activation goals, mood monitoring and
avoidance behaviours in the period leading up to the
next session).
 Planning for the future—Session 7 involves
identifying strategies that have been helpful and
setting goals for the future.
 Review and consolidation sessions—Sessions 8–10
review progress, reinforce maintenance of changes
and set further goals.
 The core principles of BA are reviewed during the
booster session (16 months postnatal) and any new
difficulties that arise are dealt with using skills
developed in the earlier sessions.
The Parenting Intervention components focus on:
 Increasing attention to infant facial and verbal cues.
 Increasing ‘contingent responding’, by guiding the
participant to attend to her baby’s signals and efforts
at communication, and to respond to her baby’s
communication in a way that is synchronous with
the baby’s signals and focus.
 Increasing opportunities for early stimulation.
The behaviour change techniques employed include:
 Providing opportunities for participants to try age-
appropriate play interactions with their infants and
receive coaching and feedback on ways to enhance
the interaction.
 Using visual aids such as homemade/low-cost toys,
illustrated case studies and prompts.
 Problem-solving with participants about ways to
overcome barriers to providing early stimulation and
nurturing care.
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The session content is distributed as follows (see Fig. 2):
Antenatal (sessions 1–4)—Core parenting principles
and activities are introduced through audio-visual mater-
ial, including demonstration videos, to prepare the par-
ticipant for the baby. Activities include attending to and
recognising infant facial and vocal expressions, contin-
gent responsiveness and communication through
singing.
Postnatal (sessions 5–10)—Extends the core principles
and activities introduced antenatally and supports the
participants in applying these during interactions with
their baby. Additionally, new modules are introduced,
including guidance around breastfeeding (including an
emphasis on EBF); different types of play (developmentally
appropriate activities, e.g. simple face-to-face games and
‘peek-a-boo’) with emphasis on contingent responding;
and supporting the participants in consulting their Road
to Health Book to recognise signs of serious illness in the
infant.
These sessions are delivered from 2 weeks postnatal
until 9 months postnatal.
In the booster session, age-appropriate opportunities
for a range of play activities are provided, because of the
rapid advances in development in the second year. The
core principles of the parenting intervention are also
reviewed and any new difficulties that arise are dealt
with using skills developed in the earlier sessions.
Personnel—recruitment, training, and supervision
The intervention is delivered by experienced lay
counsellors who have at least 2 years of counselling
experience, including working with women and children
and HIV counselling. Intervention counsellors receive 6
weeks of training based on the treatment manual,
followed by a period of supervised practice. No
counselling sessions are attempted by the counsellors
until they have been assessed as competent by the
supervising psychologist (using standardised checklists
and through observation of role-playing). The lay coun-
sellors’ first sessions are reviewed, and any competency
issues are addressed through additional training. The
counsellors receive weekly supervision from the trial
psychologist as well as added supervision from therapy
supervisors who are more senior counsellors. Ongoing
training is also conducted through workshops.
Fidelity The fidelity and competency of the lay
counsellors are monitored through several measures:
 The lay counsellors complete a Fidelity Checklist for
every module.
 Sessions are audio-recorded (if participants consent)
and a sample of audio recordings is scored by the
supervising psychologist and feedback is provided as
needed.
 The trial psychologist conducts periodic in-person
therapy observation with all therapists to identify
any additional training needs.
 A sample of audio recordings is scored by an
independent assessor to provide a formal assessment
of fidelity to the intervention.
 Weekly supervision meetings are conducted by an
experienced psychologist who records fidelity and
competence. Retraining is conducted as needed.
Enhanced Standard of Care (ESoC)
Standard of Care in the community In the study
community, mental health services for all women in the
perinatal period are coordinated from the local
Department of Health (DoH) district hospital. The local
DoH district hospital includes a psychology department,
with a full-time clinical psychologist and psychiatric
nursing staff as well as a crisis centre. The crisis centre
Fig. 2 Participant timeline
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provides counselling and forensic services to victims of
gender-based violence, delivered by the psychologist, dis-
trict surgeon, and medical and nursing staff. The local
DoH district hospital provides acute care for psycho-
logical and psychiatric emergencies, whilst patients re-
quiring higher levels of care are referred to tertiary
centres. The psychology department provides inpatient
and outpatient care. Furthermore, the staff from the
psychology department rotate to the local primary health
clinics. There is a psychiatric unit (inpatient and out-
patient facilities) in a tertiary referral hospital in a neigh-
bouring district. A psychiatrist from the unit provides
remote consultation to staff at the local district DoH
hospital as well as holding monthly ward rounds and a
psychiatric outpatient clinic at the hospital.
In addition to this standard of care available to women
in the perinatal period in the study community, the
study team provides training in the identification, initial
management and referral of perinatal mental health
problems to all antenatal care staff at the recruiting
clinics. The training is informed by materials and
support provided by the Perinatal Mental Health Project,
based at the University of Cape Town [58] , and
delivered by an experienced clinical psychologist. To
ensure standardisation across the clinics, the training
was conducted at the beginning of the trial and is
refreshed periodically every 6 months throughout the
trial. Women in both arms of the trial have access to
these primary health care and hospital-based mental
health services.
Enhanced Standard of Care (ESoC) In addition to the
standard of care in the district, the ESoC arm receives a
telephonic counselling support and advice intervention
which also ensures referrals and access to care where
necessary. The counselling support intervention includes
four support and advice phone calls. The ESoC call
programme was informed by the enhanced care package
used in a recent perinatal depression trial in South
Africa [57].
The telephone counselling uses questions, guided by
standardised scripts, and supportive listening to enable
the caller to assess the participant’s current emotional
wellbeing and health, and to ensure referrals and access
to care where necessary. The caller (who has had at least
2 years of counselling experience) provides advice and
supports problem-solving around managing their mental
and physical health as well as partner and family rela-
tionships. Scripts for each call have been developed to
support the caller in dealing with these issues. The caller
also guides participants to use the services and support
provided by the district DoH services. Training and
supervision support the ESoC caller to be empathic and
responsive to the participants. The caller also identifies
risk situations, including suicidal ideation, that have
arisen. The caller reports and refers these to the trial risk
management team in line with the trial risk management
protocol for further action. ESoC participants receive all
four support calls from the same support caller. The
participants are also provided with a study telephone
contact number in case of urgent need and are given
telephone credit.
In addition to the phone calls provided to the ESoC
arm, participants are assessed on 7 occasions as part
of the trial (baseline and six follow-up assessments)
(both arms) by trained assessors which enables the
identification of problems of significant clinical risk
or concern. When these arise, they are evaluated by
the team which includes a full-time on-site clinical
psychologist. This is followed by initial management
and onward referral to medical, psychological, and so-
cial services depending on the case. Psychological
cases are managed by the trial risk management team
and the AHRI Clinical Research Department. An ini-
tial assessment is always provided by the trial clinical
psychologist. Where appropriate, the psychologist un-
dertakes initial management and follow-up to ensure
timely assessment and care without overburdening the
local DoH services. The trial psychologist liaises with
and makes referrals to the local DoH psychologist
and the Department of Social Development (DSD)
(social services) as necessary. Support for medical and
social cases is provided by the AHRI Clinical Re-
search Department. In collaboration with this depart-
ment, the trial has established referral pathways and
working relationships to the local DoH and DSD. In
addition, all referrals are actively monitored until care
has been accessed and, where necessary, the trial
team continues to follow up.
Session structure of ESoC calls Participants receive
two antenatal calls (2 weeks post-enrolment and at 36
weeks of gestation) and two postnatally (2 weeks and 4
months postnatal). Each call follows the same structure:
1. Connect and check-in—To enquire about their
emotional, social and physical wellbeing.
2. Suggestions and advice—Based on the participant’s
responses, the ESoC caller uses scripts to offer
suggestions and advice on actions the participant
can take to manage their mental health, health or
relationship difficulties.
3. Health information—The ESoC caller offers health
information messages linked to the participants’
stage of pregnancy or parenting and offers advice
on the availability of services and makes referrals
where needed.
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In addition, brief health information is provided to the
participant during each call:
1. Early Pregnancy Call—Information on attending
antenatal visits, managing HIV treatment;
2. Late Pregnancy Call—Information on managing
HIV treatment, healthy pregnancy and planning for
delivery;
3. Early Postnatal Call—Information on infant feeding,
managing infant’s sleep and routines;
4. Late Postnatal Call—Information on infant feeding,
managing infant’s sleep and routines, managing
HIV treatment, parenting
Materials Electronic tablets assist the ESoC caller with
scripts to deliver the ESoC calls and to keep a record of
session content. The caller also completes a checklist for
each call.
A parenting leaflet developed by UNICEF South Africa
(with the Department of Education) is given to all
participants in the study at the clinic at enrolment.
Personnel—recruitment, training, and supervision
The ESoC is delivered by an experienced ESoC caller
who has at least 2 years of counselling experience,
including working with women and children, and
providing HIV counselling. The ESoC caller attends a 4-
week intensive training workshop followed by a mock
telephone call competency assessment and intensive
supervision over the first 2 months. Periodic refresher
training is provided. The training includes the identifica-
tion of risk situations, including suicidal ideation. The
ESoC caller receives weekly supervision and debriefing
with a trained counselling supervisor, to support and fa-
cilitate referrals in risk cases and in managing the logis-
tical aspects of the ESoC. The caller contacts the ESoC
supervisor between supervision sessions if issues of con-
cern or uncertainty arise.
Fidelity The fidelity and competency of the ESoC callers
are monitored through several measures including
supervision, debriefing and recordings and rating of
ESoC calls (if participants consent).
Criteria for discontinuing or modifying allocated
interventions {11b}
Criteria for discontinuation of allocated interventions
include situations where participants have requested
discontinuation or have or have developed another
major physical illness or injury which makes it too
challenging for the participant to continue. In specific
situations, such as following bereavement or a major life
event, the Principal Investigators can agree to a limited
number of additional therapy sessions or ESoC calls.
Strategies to improve adherence to interventions {11c}
Several strategies are implemented to improve
adherence, including clear communication to the
participants about intervention timing and structure
(including the provision of an intervention schedule and
homework sheets). Text reminders and/or calls to
participants are made when therapy/ESoC sessions are
missed. Data is routinely collected during each
intervention session using checklists to monitor
adherence to intervention content which are
frequently reviewed.
Relevant concomitant care permitted or prohibited
during the trial {11d}
Concomitant psychopharmacological treatment is not
commonly prescribed in the population under study. For
both the intervention and ESoC groups, where it is
deemed necessary by a health care provider,
concomitant psychopharmacological care is permitted,
and carefully documented and monitored. Additional
care in the form of psychological therapy or treatment is
permitted in circumstances to manage risks such as
significant suicidality or significant social harm, such as
domestic violence. In such cases, we make appropriate
referrals to health or social services following well-
established referral pathways and risk management pro-
tocols. Furthermore, for the ESoC arm additional refer-
rals and interventions for psychological or social care in
the public services are supported and encouraged as part
of the four support and advice calls. Careful records are
kept of all referrals. Provision and participation in sup-
plementary child stimulation activities, and/or attend-
ance at childcare or educational centres or nursery
schools is permitted across both allocations.
Provisions for post-trial care {30}
A trial clinical psychologist is employed on a full-time
basis to supervise intervention delivery and to provide
ancillary psychological care to participants in emergen-
cies who meet criteria, including those expressing sui-
cidal ideation and intent, those experiencing life-
threatening trauma, violence and/or close family be-
reavement. In cases of infant death or stillbirth, add-
itional bereavement sessions are offered. Following the
final trial outcome assessment (24 months postpartum),
all participants with high-risk profiles will be assessed by
the trial psychologist, who will provide initial manage-
ment. Those participants who require additional and on-
going care will be referred to the local DoH and DSD
services as necessary. Additionally, psychological ses-
sions may also be offered to participants by the trial
psychologist. If the therapy intervention is shown to be
successful, in line with the pre-trial consultations, we
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will train local primary healthcare workers to provide
the combined therapy locally.
Outcomes {12}
Primary outcomes The following primary outcomes are
shown in Table 1:
1. Child cognitive development at 24 months of age,
assessed using the Bayley Scales of Infant and
Toddler Development III (BSID-III) cognitive
subscale.
2. Maternal perinatal depression at 12 months
postnatal assessed using the Edinburgh Postnatal
Depression Scale (EPDS).
Secondary outcomes The 10 secondary outcomes and
the associated measures are summarised in Table 2 and
Table 3.
Participant timeline {13}
Participant timeline is shown in Table 4.
Sample size {14}
The first primary outcome is the cognitive subscale on
the BSID-III at 24 months of age. To achieve power of
over 90% (two-sided t-test with a significance level of
0.05), and assuming an estimated difference of 6 points
(SD 15), a total sample size of 396 women (198 per arm)
is required. This calculation takes into account geospa-
tial clustering (28 clusters per arm with an intra-cluster
correlation coefficient (ICC) of 0.05) and ‘counsellor ef-
fect’ in the intervention arm (4 lay counsellors with an
ICC of 0.05). To take account of attrition of up to 25%,
a total sample size of 528 women is being recruited (264
per arm, 48–60 geospatial clusters, 9–11 women per
cluster).
Using the EPDS assessment with a standard deviation
of 5, with the same assumptions of clustering as above, a
difference of 2 points between trial arms (not adjusting
for baseline or repeated measurements) could be
detected with 90% power and a 5% two-sided signifi-
cance level. Analysis using repeated measures, taking
into account within-participant correlation over time,
would allow smaller differences to be detected with the
same power
Recruitment {15}
Recruitment and screening take place from 15 DoH
Primary Health Care Clinics within a sub-district in
KwaZulu-Natal offering maternity services.
Recruitment strategy The recruitment process is led by
recruiters from the trial team with support from DoH
antenatal nurses and clinic clerks.
Recruitment into the trial occurs through a four-stage
process:
(1) Identification of potential participants—Clinic
records are reviewed by antenatal nurses and clinic
clerks at antenatal clinics to identify HIV-positive,
pregnant women (gestational age 23–33 weeks) over
the age of 16 years. The nurses and clerks reassure
the potential participants that their clinical care will
not be compromised by participation.
(2) Referral to recruiter—If the identified potential
participants consent, they are referred to a trial
recruiter who explains the trial procedures and
screens for additional eligibility criteria.
(3) Depression screen—Administration of the EPDS if
the potential participant meets all other eligibility
criteria.
(4) Consent processes—Written consent and
scheduling of baseline assessment at home for
participants who fulfil all inclusion criteria,
including an EPDS ≥ 9.
The baseline assessment is conducted at the home at
which point the GPS location is verified. The participant
is randomised (based on their geospatial cluster)
following the baseline assessment.
Only participants who were diagnosed with HIV at
least 2 weeks previously and have been initiated on ART
are recruited.
If during the screening or recruitment process a
participant indicates thoughts of self-harm on the
self-harm item of the EPDS, this initiates a risk man-
agement response and immediate notification is then
made to the Trial Coordinator and Trial Psychologist.
The Trial Psychologist then makes a psychological as-
sessment in order to establish whether there is active
suicidal intent or behaviours. It these are present, the
psychologist undertakes initial management including
Table 1 Primary outcomes
Domain Measure Metric Method of
aggregation
Timepoint
Child cognitive development at
24 months of age
Bayley Scales of Infant and Toddler Development
III (BSID-III) cognitive subscale (Composite Score)
Mean difference Mean and SD 24 months
postnatal
Maternal depression Edinburgh Postnatal Depression Scale (EPDS), total score Mean difference Mean and SD 12 months
postnatal
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telephonic follow-up at 24 h, 48 h and 72 h, and refer-
ral to the DoH Psychologist at the local hospital as
appropriate. Following this management, if the poten-
tial participant is no longer at risk for self-harm, and
still meets recruitment criteria, then they will be of-
fered participation in the study.
Assignment of interventions: allocation
Sequence generation {16a}
The unit of randomisation is the cluster using the
geospatial location of the participant’s home. There are
approximately 300 neighbourhoods in the region
included in this trial; these are defined by geographical
area as well as population density so that they are
equivalent in terms of sample size. The distinct
neighbourhoods have been merged into 48–60 clusters
to ensure comparable clusters in terms of key indicators,
including population size. This clustering approach, and
the important role of randomisation in this trial, has
been presented to, and approved by, the AHRI
Community Advisory Board.
Concealment mechanism {16b}
Allocation concealment is ensured by a two-step enrol-
ment procedure whereby neither the recruiter nor the
Table 2 Secondary outcomes
Domain Measure Metric Method of
aggregation
Timepoint
1 Maternal depression Edinburgh Postnatal Depression
Scale (EPDS), total score
Mean
difference
Mean and SD End of pregnancy;
24 months postnatal
2 Maternal anxiety Generalized Anxiety Disorder 7-item
(GAD-7) scale, total score
Mean
difference




Viral Suppression (Yes/No) Risk ratio Frequency and
percentage
End of pregnancy;
12 weeks, 12 months,
24 months postnatal
4 Exclusive breastfeeding Exclusive breastfeeding at
6 months (Yes/No)
Risk ratio Frequency and
percentage
6 months postnatal
5 Adherence to infant immunisation
schedule over the 24-month
postnatal period
No. of immunisations recorded Mean
difference
Mean and SD 12 weeks, 12 months,
24 months postnatal
6 Infant diarrhoea Any maternal report of diarrhoea over the
previous 14 days.
Risk ratio Frequency and
percentage
12 weeks, 6 months,
12 months, 24 months
postnatal
7 Cognitive and emotional stimulation
within the home environment
Early Childhood Development section of
Multiple Indicator Cluster Surveys (MICS6)
Questionnaire for cognitive and emotional
stimulation for children under five, total score
Mean
difference
Mean and SD 12 months, 24 months
postnatal
8 Infant behaviour Parenting Stress Index, Short Form (PSI/SF:
parent-child dysfunctional interaction
subscale and difficult child subscale, total score
Mean
difference
Mean and SD 12 months postnatal
Externalising subscale of Child Behaviour
Checklist (CBCL), total score
Mean
difference
Mean and SD 24 months postnatal
9 Child language development Language subscale of the Bayley Scales
of Infant and Toddler Development
III (BSID-III), Composite score
Mean
difference
Mean and SD 24 months postnatal
10 Child growth (infant height and
weight at 24 months)




Mean and SD 24 months postnatal




Relationship conflict questions adapted from the Romantic
Partner Conflict Scale [59]. Support questions used from
social support measure previously validated in South Africa [60].
Baseline, end of pregnancy, 12 weeks,
12 and 24 months
Rumination Brief Rumination Response Scale [61] Baseline, end of pregnancy, 12 weeks,
12 and 24 months
Maternal recognition of infant
faces and sounds
Stimuli task Baseline, 12 months
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assessor establishing eligibility know to which arm the
clusters have been allocated.
Implementation {16c}
The 48–60 geospatial clusters are randomly allocated to
the integrated intervention or ESoC with an allocation
ratio of 1:1 using a random sequence generated by a
senior statistician at the National Perinatal Epidemiology
Unit (NPEU), University of Oxford (using Stata/SE
version 13 for Windows). The randomisation schedule is
sent to AHRI using a secure web link and implemented
by the local data management team. None of these
parties is involved in the implementation of trial
activities (recruitment, assessments, therapy).
Assignment of interventions: blinding
Who will be blinded {17a}
Participants are not informed at enrolment as to which
arm they are allocated to ensure the blindness of the
recruiters and assessors. Rather, participants are
informed that a trial counsellor will contact them. The
intervention counsellors or the ESoC caller reveal the
arm to which the participant has been allocated when
they first make contact.
The recruiters and assessors are blinded to the
treatment allocation arm. Furthermore, the assessors are
independent of the lay counsellors performing the
counselling sessions and blind to treatment allocation.
The two primary endpoints are assessed by different
independent assessors (at 12 and 24 months).
Procedure for unblinding if needed {17b}
In the event of inadvertent unblinding of an assessor,
standard operating procedures are in place to reduce the
impact and ensure that the assessor is never allocated to
the given participant in future assessments.
Minimisation of contamination Recruitment staff are
located at clinics whilst intervention staff operate from a
separate AHRI campus to minimise contact between
recruitment and other staff. ESoC caller and lay
counsellors operate separately within different scopes of
work in distinct offices, are line-managed and supervised
by different individuals, use separate transport services
and attend separate meetings to reduce the risk of
Table 4 Participant timeline
Assessment (A) A1 Allocation A2 Birth A3 A4 A5 A6 A7















Screening form and eligibility checklist X
Demographic and socio-economic status X
Tracing and location information X X X X X X X






EPDS X X X X
GAD-7 X X X X
Maternal Antiretroviral treatment
adherence
X X X X X
Exclusive Breastfeeding X
Infant immunisations X X X
Infant diarrhoea X X X X
Cognitive and emotional stimulation
(MICS)
X X




Child Growth (weight and height) X X X
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unblinding. They are trained not to share information
that could compromise the blinding or the integrity of
the trial. Any instances of unblinding are recorded and
assessed at the conclusion of the trial.
Data collection and management
Plans for assessment and collection of outcomes {18a}
Participants in both arms receive 6 assessments
following the baseline assessment: (1) end of pregnancy;
(2) 6-day postnatal screener, (3) 12-week postnatal, (4) 6
months; (5) 12 months, (6) 24 months. The points at
which primary and secondary outcome data are collected
are outlined in Tables 1, 2, and 3. Assessments take
place at home, except for the 24 month assessment, in-
cluding the primary endpoint BSID-III assessment,
which takes place in participating clinics.
Table 5 outlines the standardised data collection tools
used in the study. Below we outline tools specific to this
study.
Maternal recognition of infant faces and sounds
The participant’s ability to accurately interpret and
respond to infants’ emotional cues is assessed using a
subset of stimuli baby faces developed by rigorous
validation methods in Brazil [81] and a sample of
standardised baby vocalisations [82, 83]. Mothers are
asked to indicate their interpretation of both the facial
expressions (‘happy’, ‘neutral’, ‘sad’) and the vocalisations
(positive ‘laughs’ neutral ‘babbles’ and ‘negative ‘cries) on
an electronic tablet screen using a vertical visual
analogue scale. The faces used for this sample include
Caucasian, African and mixed-race infant faces and the
images are presented in greyscale and matched in size
and luminosity [84]. The task takes around 15 min to
complete.
Economic evaluation
Costing is conducted from a societal perspective,
including financial costs to providers, opportunity costs
of diverted provider resources (such as time of staff not
paid on the trial, space) and financial (e.g. travel, time
off work) and opportunity costs (e.g. time away from
unpaid productive activities) to participants. We
distinguish between research costs and operational costs
to allow estimation of the cost of replication in non-
research settings. The analysis involves three levels with
increasing complexity. The first level involves a cost-
utility analysis of the intervention with the primary and
secondary outcome included in turn: the cost per im-
provement in cognitive development; the cost per im-
provement in maternal depression. The second level
involves cost-effectiveness analysis using disability-
adjusted life years (DALYs) averted. Improvements in
child cognitive development and maternal depression
are converted to DALYs based on assumptions regarding
the duration of the observed benefit. The cost per DALY
is then calculated. The third level compares costs to a
vector of benefits, including indicative estimates of long-
term gains (based on simple models), such as improved
education outcomes and increased income in adulthood.
Nested qualitative study
A qualitative sub-study is conducted alongside the trial,
using semi-structured interviews with both the lay coun-
sellors who delivered the intervention and with a sample
of participants from each study arm. The sub-study aims
to investigate the acceptability, challenges, enablers and
potential benefits of the combined intervention com-
pared to ESoC. The sub-study also investigates the ac-
ceptability and effectiveness of the therapist training and
therapy supervision for this intervention. The data will
be analysed using grounded theory principles and the-
matic content analysis [85, 86].
Plans to promote participant retention and complete
follow-up {18b}
We have developed a standard operating procedure to
guide and promote retention and follow-up. This in-
cludes maintaining a regular schedule of assessments.
Tracing and follow-up methods include text, telephone
calls and in-person track and tracing. Participants are
encouraged to notify the trial staff if they change their
telephone number or address. Retention in the study
community in previous clinical trials using these strat-
egies has resulted in high retention rates. If participants
discontinue the intervention (therapy/ESoC), they con-
tinue to receive assessments, including the primary out-
come assessments (providing their consent).
Data management {19}
Study data are collected and managed using a secure,
web-based data collection platform on encrypted tablet
computers which are securely uploaded to a central ser-
ver hosted at AHRI. The platform is a secure, web-based
software platform designed to support data capture for
research studies, providing (1) an intuitive interface for
validated data capture; (2) audit trials for tracking data
manipulation and export procedures; (3) automated ex-
port procedures for seamless data downloads to com-
mon statistical packages and (4) procedures for data
integration and interoperability with external sources.
The tablets are encrypted, and all documents are stored
safely under confidential conditions. On all trial-specific
documents, other than the signed consent forms, the
participant is referred to by the trial participant number,
not by name.
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Confidentiality {27}
The trial staff ensure that the participants’ anonymity is
protected as far as possible. The trial complies with GCP
and established practice which requires data to be
anonymised as soon as it is practical to do so. Audio and
video recordings are stored on a secure server with very
limited access (to senior research team members and
researchers working directly with a particular participant
or directly involved in coding data). Participants are
informed that audio-visual recordings will not be used
outside of the team of researchers, and this is outlined
in the consent form. Following the completion of the
trial, the data will be downloaded and de-identified.
Plans for collection, laboratory evaluation and storage of
biological specimens for genetic or molecular analysis in
this trial/future use {33}
Not applicable, no biological samples are collected.
Statistical methods
Statistical methods for primary and secondary outcomes
{20a}
The primary inference will be based on the BSID-III
cognitive score at 24 months and the EPDS at 12
months. For the primary outcomes and other continuous
outcomes, the mean (SD) will be presented by the allo-
cation group, and the mean difference (plus 95%
Table 5 Data collection tools
Instrument Description Outcome Contextual validity




A comprehensive objective assessment
administered face-to-face by a qualified inde-
pendent assessor to assess child development.
Only the cognition and language subscales
are administered.
Child cognitive and language
development
Validated in South Africa [63, 64] with
reported values similar to the reference




10-item questionnaire of perinatal depressive
symptoms over the last 7 days assessed on a
scale of 0 to 3.
Maternal depressive
symptoms
Widely used and validated in Africa and South
Africa, including use amongst antenatal
populations [66]. Has been validated in the
study population against a structured clinical
interview for depression (DSM-IV) showing
good specificity (93%) and sensitivity (68%) for




Externalising subscale (attention problems and
aggressive behaviour syndrome scales) of the
CBCL. 24 items, assessed on a scale of 0 to 2.
Parental self-report.
Child externalising behaviour Has been shown to be reliable in Africa [70],
and to have high (> 90%) sensitivity and
specificity for identifying behavioural
emotional problems compared to a clinical
diagnosis by a psychiatrist in other LMICs [71]





Measure of parenting stress related to three
domains: the parental role, the parent-child re-
lationship, and the degree to which the parent
finds the child difficult. The scale comprises 36
statements, which are scored 1 (strongly dis-
agree) to 5 (strongly agree) and can be
summed to reflect the total score for each
domain.
Maternal perception of child
behaviour (Dysfunctional
Interaction and Difficult Child
subscales)




A 5-item questionnaire assessing depressive
rumination assessed on a scale of 0 (never) to
4 (always).
Maternal rumination A validated and reliable measure of




7-item questionnaire assessing symptoms of
generalised anxiety disorder over the previous
2 weeks. Scores
Maternal anxiety Has been widely used in the study setting
and has shown good reliability [76, 78].
Multiple Indicator
Cluster Survey (MICS)
Specific questions from the Early Child
Development module of the UNICEF ‘Multiple
Indicator Cluster Surveys’ (MICS) under five are
used to assess cognitive and emotional
stimulation at home. Items are mostly scored
on a dichotomous scale of 0 and 1 except for
the question about how many children’s
books or picture books a mother has for her
child (0 = none, 1 = a number of books and 2
= ten or more books).
Cognitive and emotional
stimulation.
Validated survey used in over 100 countries
over the past two decades, also used in large
scale surveys in 27 African countries [79, 80].
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confidence interval) will be estimated using mixed-
effects linear regression. For binary outcomes, the num-
ber and percentage with the outcome will be presented
by the allocation group, and the risk ratio (plus 95% con-
fidence interval) will be estimated using a mixed-effect
binomial or Poisson regression model.
The unit of randomisation is a geospatial cluster as
outcomes are collected at the individual level, hence the
unit of analysis is the mother and the infant. There is
also an additional level of clustering by the counsellor
delivering the intervention. The lack of independence
amongst individuals in the same cluster and standard
methods of analysis will underestimate the standard
error of the treatment difference yielding p values that
are too small. To account for the correlation of
outcomes within clusters, the geospatial cluster and
counsellor identifier will be fitted as random effects,
with counsellor nested within the geospatial cluster. The
intra-class correlation coefficients for geospatial cluster
and counsellor will be estimated.
For the EPDS and the GAD-7, a repeated measures
model will be fitted, including the baseline, end of preg-
nancy and 12-month and 24-month scores. For the cog-
nitive and emotional stimulation at home outcomes, a
repeated measures model will be fitted including the 12-
and 24-month scores. Mixed-effects models with
maximum-likelihood estimation allow participants with
incomplete repeated measures data to be included in the
model, contributing to the estimation of model parame-
ters. The mean scores with 95% confidence intervals will
be plotted over time by the allocation group.
In addition to adjusting for important baseline
differences between randomised groups, any differences
between participants followed up to 24months and
those lost to follow-up will be adjusted for in the final
models. Both unadjusted and adjusted models will be fit-
ted, but the primary inference will be based on the ad-
justed model which provides unbiased estimates if the
outcome data is missing at random (i.e. only dependent
on observed characteristics).
Interim analyses {21b}
A Data Monitoring and Safety Board (DSMB),
independent of the trial organisers and sponsors, has been
established with the remit to review trial progress. The
terms of reference for the DMSB were agreed upon at
their first meeting and documented in the DSMB charter.
The DSMB is chaired by a senior clinical trialist, and
members include two statisticians and a clinician. Interim
data analyses are supplied, in strict confidence, to the
DSMB, as frequently as the chair requests and meetings
are held at least annually. Based on interim data on the
trial’s outcomes, adverse event data, accumulating
evidence from other trials and any other relevant
evidence, the DSMB will inform the Trial Steering
Committee (TSC) if, in their view, there is proof beyond a
reasonable doubt that the data indicate that any part of
the protocol under investigation is either clearly indicated
or contra-indicated, either for all trial participants or for a
particular sub-group of trial participants. A difference of
at least 3 standard errors in the interim analysis of a major
endpoint may be needed to justify halting, or modifying,
such a study prematurely.
Methods for additional analyses (e.g. sub-group analyses)
{20b}
Pre-specified sub-group analysis of factors known to be as-
sociated with infant cognitive development—maternal edu-
cation, socio-economic class, the severity of depression at
trial entry and infant sex—will be performed for the infant
cognitive development outcome at 24months using the
statistical test of interaction. Sub-group analysis based on
maternal education, socio-economic class and infant sex
concerning maternal depression at 12months will also be
performed. The sub-groups will be categorised as follows:
 Maternal education (primary completed or below;
grade 10; matriculation or above).
 Socio-economic status (paid employment yes/no).
 Severity of depression at trial entry (continuous).
 Infant sex (male/female).
Methods in analysis to handle protocol non-adherence and
any statistical methods to handle missing data {20c}
Women with outcome data will be analysed in the
groups to which they are randomly assigned, regardless
of deviation from the protocol or treatment received
(modified ITT population). Women whose infant died
during the trial will also be included unless they
withdrew consent to participate further in the trial.
The number and percentage of individuals missing data
for outcome measurements that are based on summing
items to give overall scores (e.g. EPDS, GAD-7, and sub-
scales of the PSI/SF and CBCL) will be described. Missing
items will be imputed if ≤ 20% are missing using the me-
dian score of completed scale items unless alternative
guidance is provided in the scoring manual.
A multiple imputation analysis will be performed for
the primary infant and maternal outcome if attrition
exceeds 5%. The multiple imputation model will include
baseline characteristics and outcome measures collected
before the missing assessment, which are associated with
missing status.
Plans to give access to the full protocol, participant level-
data and statistical code {31c}
Data will be available beginning 9 months and ending
36months following main article publication to
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researchers who provide a methodologically sound
proposal that purposes to achieve aims in the approved
proposal and /or for individual participant data meta-
analysis. Data is documented and stored on the AHRI
Data Repository (https://data.ahri.org) with a digital ob-
ject identifier (doi) and can be accessed with permission
and in line with AHRI policies and procedures. Data re-
questors will need to sign a data access agreement before
any data can be shared. In addition, Study Protocol and
Statistical Analysis Plan documents will be available.
Data sets associated with publications will be made
available in line with Wellcome Trust data policies and
journal requirements.
Oversight and monitoring
Composition of the coordinating centre and trial steering
committee {5d}
This trial is managed and coordinated by a trial group
(management, operational and data management sub-
groups) with regular advice and consultation from the inves-
tigators’ group and the AHRI Clinical Research Department.
The trial group composes of management, operational
and data management sub-groups. The management sub-
group consists of the principal investigators, trial man-
ager, trial coordinator, and trial psychologist. The group
meets at least once a week virtually to discuss and manage
major trial operational challenges (screening, recruitment,
assessments, therapy/ESoC), logistics, adverse events (AE)
and severe adverse events (SAEs), staffing, and trial report-
ing and monitoring. Trial reporting and monitoring in-
cludes the management and reporting of AEs and SAEs
and trial progress using summary statistics and graphs.
The operational sub-group includes the four trial compo-
nents (recruitment, assessment, therapy, ESoC) and is
managed by the trial coordinator. The operational teams
meet at least once a week, with individual meetings and
contact points as needed. The four teams are operated
separately to ensure blinding. The data management sub-
group meets weekly and includes the AHRI data manager,
trial manager and trial coordinator.
The investigators’ group consist of the trial
management group and experts (investigators) in
maternal health and early child development. The
investigators are consulted regularly dependent on their
specific roles and small sub-group meetings are orga-
nised as needs be. The whole group meets formally every
3 months. Trial Progress Reports containing updates,
summary statistics and graphs and discussion points are
submitted for these meetings.
The trial group confers regularly with the AHRI
Clinical Research Department, primarily regarding SAE
and AE management. The trial coordinator has frequent
meetings with the head of the Clinical Research
Department and attends regular AHRI wide project
coordination meetings to ensure that the trial
implementation is coordinated with awareness of other
research activities in the study community.
The Trial Steering Committee (TSC) acts as the
oversight body for this trial on behalf of the Sponsor/
Funder and it should also provide advice through its
independent Chair on all aspects of the trial. All
substantial issues regarding the trial must go to the TSC
for consideration. The Data Safety Monitoring (DSMB)
is advisory to the TSC and the DSMB makes
recommendations to the TSC based on the interim data.
The TSC oversees the timely analysis, writing up and
publication of the main trial results. The independent
members of the TSC will have the opportunity to read
and comment on the proposed main publications of trial
data before submission. The TSC is made up of the
chair, three independent members, including an
experienced trials statistician. The TSC meets with the
trial management team and an independent observer
from the funding body at least annually and ad hoc as
required to discuss trial issues.
Composition of the data monitoring committee, its role and
reporting structure {21a}
The Data Monitoring and Safety Board (DSMB) consists
of a chair (senior clinical trialist), two statisticians and a
clinician. Interim data analyses are supplied, in strict
confidence, to the DSMB, as frequently as the chair
requests and meetings are held at least annually. The
DSMB is independent of the trial organisers and
sponsors. The terms of reference for the DMSB were
agreed upon at their first meeting and documented in
the DSMB charter. Based on interim data on the trial’s
outcomes, adverse event data, accumulating evidence
from other trials and any other relevant evidence, the
DSMB will inform the Trial Steering Committee (TSC)
if, in their view, there is proof beyond a reasonable
doubt that the data indicate that any part of the protocol
under investigation is either clearly indicated or contra-
indicated, either for all trial participants or for a particu-
lar sub-group of trial participants. A difference of at least
3 standard errors in the interim analysis of a major end-
point may be needed to justify halting, or modifying,
such a study prematurely.
Adverse event reporting and harms {22}
The processes of risk identification and management
have been developed and tested. The trial has, in
collaboration with the AHRI Clinical Research
Department, identified and established referral pathways
for the management of risk, including referrals to the
local DoH and DSD services. The AHRI Clinical
Research Department assists with the management of
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medical SAEs. We have developed a protocol for the
management of these events and reporting at
appropriate times to the DSMB.
The trial distinguishes between severe adverse events
(SAEs) and adverse events (AEs). SAEs pose a high risk to
the mother and/or enrolled child and require urgent
attention and management. SAEs include maternal/child
death; physical illness requiring hospitalisation ≥ 5 days;
severe psychological or psychiatric illness (may require
hospitalisation; current suicidal ideation with intention
and/or a plan; self-harm; serious social harm (e.g. interper-
sonal violence-causing immediate danger or risk); stigma,
emotional harm or risk of displacement/insecure housing
(as a direct result of trial participation); and inadvertent
disclosure of participants HIV status or breach of confi-
dentiality (intentionally or unintentionally by research
staff). Details of the SAE and a brief management plan are
communicated to the DSMB Chair within 24 h of the
team being notified of the SAE. Furthermore, SAEs are re-
ported to the HSRC and OxTREC ethics committees
within 7 days of the team being notified of the SAE.
In contrast, AEs are defined as events that do not pose
an immediate risk to the mother/infant but require
management and attention to prevent escalation into a
high-risk event (SAE). These include relationship prob-
lems/conflicts, feelings of hopelessness and suicidal
thoughts without serious intent or plans. These are
monitored and recorded and reported to the ethics com-
mittees and the DSMB as AEs.
Additional information about the management of risk
cases is documented under ‘Enhanced Standard of Care’
on page 23.
Frequency and plans for auditing trial conduct {23}
The trial is being conducted in accordance with the
currently approved protocol, GCP, relevant regulations
and SOPs. The risk management protocol and
operational SOPs are reviewed as necessary throughout
the trial to reflect significant changes to the protocol or
outcomes of monitoring activities.
The AHRI research data management team conducts
frequent checks of the trial, including recruitment
patterns and the quality and completeness of data using
relevant software as well as manual checks. Lists of
missing data will be generated automatically for regular
checks. Furthermore, the data collection software is
designed to optimise correct data capture by specifying
the data and values required.
Plans for communicating important protocol amendments
to relevant parties (e.g. trial participants, ethical
committees) {25}
Any protocol modifications which may influence the
study conduct, potential benefit of the participants,
participants’ safety, study objectives, study design,
participant population, sample sizes, study procedures,
interventions, assessments or significant administrative
aspects will require a formal amendment to the protocol.
Such amendment will be agreed upon by the Principal
Investigators and the Investigators and submitted to
OxTREC and HSRC for formal ethical approval before
implementation. Participants will be informed of any
important protocol amendments if deemed necessary.
Authorship statement
The success of the trial depends upon a large number of
collaborators. Credit for the trial findings will be given
to all who have collaborated and participated in the trial
including collaborators, members of the trial committees
and trial staff. The authorship of the primary results
paper arising will comprise all who have made a
substantial intellectual contribution to the study
(including the research question, design, analysis,
interpretation), and so is expected to include all main
applicants on this study who fulfil all four criteria of the
ICMJE recommendations for authorship (www.icmje.
org). The writing will be the responsibility of a writing
committee including all of the investigators and core
trial management team led by the Chief Investigator. All
contributors to the trial will be listed at the end of the
manuscript, with their contribution identified. It is the
intention to publish at least two peer-reviewed articles
detailing (i) the analysis of primary and secondary out-
comes and (ii) the mechanisms by which the interven-
tion improves infant outcomes will be evaluated in an
exploratory analysis.
Dissemination plans {31a}
The trial results will be disseminated to participants, the
public, researchers, healthcare professionals and
policymakers. The study participants will be informed of
the findings from the trial. The trial results and their
implications for policy and practice will be presented in
the form of a technical brief to the district, provincial
and national departments of health and disseminated
nationally through webinars. The technical brief will also
be disseminated to relevant mental health and public
health charities and non-governmental organisations.
With support from the AHRI community advisory board
and public engagement office, we will disseminate the
findings to the local community. The trial results will be
presented at national and international conferences.
Publications will be submitted to peer-reviewed, open-
access journals in line with funder requirements.
Discussion
There is a considerable treatment gap for mental health
disorders amongst people living with HIV in LMICs [87],
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of which HIV-positive women in the perinatal period are
considered especially vulnerable to poor mental health
[3]. Addressing this treatment gap requires innovative
programmes that can be integrated sustainably into exist-
ing primary care programmes with user involvement to
create a holistic approach. Importantly, treating both ma-
ternal perinatal depression and enhancing child develop-
ment has the potential to result in positive health and
human capital benefits. If the integrated intervention is
found to be effective, the ultimate aim is that it will be
scalable at different levels, including local, provincial, na-
tional and international, and critically include users,
stakeholders, the general public, policymakers and aca-
demic beneficiaries.
The intervention is potentially generalisable to
countries with high levels of HIV as part of initiatives to
prioritise antenatal and postnatal health care for
mothers and children within fragile health systems.
The trial has developed an electronic treatment
manual that guides the lay counsellors as they deliver
BA and parenting support. There is a demand for
improving the competencies and skills of the mental
health and early childhood development workforce.
Building capacity entails not only training frontline
workers, many of whom are lay workers but
contributing to an evidence-based body of knowledge
that will be informative for future implementation strat-
egies in community systems. The knowledge base will
also contribute to supervision and training systems.
Trial status
The trial started recruitment on 04/04/2018.
Recruitment was suspended on 16/03/2020 due to the
COVID-19 pandemic and was resumed briefly for 6
weeks in November and December 2020 but had to be
paused in December 2020 due to further COVID-19 re-
strictions. Recruitment resumed again in March 2021
and was the closed on 13th of July 2021. The trial is cur-
rently operating on protocol version V1.05 (26th of May
2021 ).
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